{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:24:50Z","timestamp":1791645890906,"version":"4.3.4"},"reference-count":37,"publisher":"Informa UK Limited","issue":"3","funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["CNV0025894"],"award-info":[{"award-number":["CNV0025894"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2017,3,4]]},"DOI":"10.1080\/1744666x.2017.1288097","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T13:31:51Z","timestamp":1485869511000},"page":"181-188","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":74,"title":["Adalimumab for the treatment of uveitis"],"prefix":"10.1080","volume":"13","author":[{"given":"Kara C.","family":"LaMattina","sequence":"first","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra A.","family":"Goldstein","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.06.014"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.09.014"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.9.844"},{"issue":"4","key":"e_1_3_2_6_1","first-page":"469","article-title":"Anti-tumor necrosis factor (TNF) therapy in rheumatoid arthritis: correlation of TNF-alpha serum level with clinical response and benefit from changing dose or frequency of infliximab infusions","volume":"23","author":"Edrees AF","year":"2005","unstructured":"Edrees AF, Misra SN, Abdou NI. Anti-tumor necrosis factor (TNF) therapy in rheumatoid arthritis: correlation of TNF-alpha serum level with clinical response and benefit from changing dose or frequency of infliximab infusions. Clin Exp Rheumatol. 2005;23(4):469\u2013474.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000055677"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0898-6568(01)00160-7"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1071924"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1996.0120"},{"issue":"1","key":"e_1_3_2_11_1","first-page":"9","article-title":"Localization of tumor necrosis factor receptor messenger RNA in normal and herpes simplex virus-infected mouse eyes","volume":"38","author":"Cunningham ET","year":"1997","unstructured":"Cunningham ET Jr., Stalder A, Sanna PP, et al. Localization of tumor necrosis factor receptor messenger RNA in normal and herpes simplex virus-infected mouse eyes. Invest Ophthalmol Vis Sci. 1997;38(1):9\u201315.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706290"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.08.025"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.03.057"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.12.034"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2007.0104"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-302292"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2015.1134581"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509852"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31339-3"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.092585"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131289"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2010.483314"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-011-1844-0"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.04.058"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.103721"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2013.06.009"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2015.12.006"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem356"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S23646"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-013-2275-x"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/560632"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-301401"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.02.018"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0922-y"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202533"},{"issue":"12","key":"e_1_3_2_37_1","first-page":"2188","article-title":"Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapy","volume":"54","author":"Furst DE","year":"2015","unstructured":"Furst DE, Kavanaugh A, Florentinus S, et al. Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapy. Rheumatology (Oxford). 2015;54(12):2188\u20132197.","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.12.011"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2014.990041"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2017.1288097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T21:12:05Z","timestamp":1772745125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2017.1288097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,13]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3,4]]}},"alternative-id":["10.1080\/1744666X.2017.1288097"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2017.1288097","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-10-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-02-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}